Cosmo Pharmaceuticals
Thursday, 10 July 2014
Acting as Irish legal advisor to publicly traded specialty pharmaceutical company, Cosmo Pharmaceuticals S.p.A. on the merger of Cosmo Technologies Ltd (Cosmo Tech) with Salix Pharmaceuticals Ltd (Salix) (U.S.) and proposed listing of Cosmo Tech on NASDAQ (Deal value +$2bn).
RELATED SERVICES
RELATED PEOPLE
RELATED LINKS